AR and hepatocellular carcinoma: Cisplatin can suppress the androgen receptor (AR) expression by increasing miR-34a-5p to suppress AR expression, and the inhibited AR may function through upregulation of ULBP2 protein, thereby enhancing NK cell function and preventing hepatocellular carcinoma progression (42).